Anesthetic Management for an Adult With Glycogen Storage Disease Type 0
Author(s) -
Airi Sakamizu,
Erika Yaguchi,
Shinsuke Hamaguchi
Publication year - 2020
Publication title -
anesthesia progress
Language(s) - English
Resource type - Journals
eISSN - 1878-7177
pISSN - 0003-3006
DOI - 10.2344/anpr-67-02-06
Subject(s) - medicine , remifentanil , anesthesia , propofol , velopharyngeal insufficiency , palatoplasty , glycogen storage disease , anesthetic , surgery , adverse effect , glycogen
A 20-year-old woman with glycogen storage disease type 0 (GSD-0) underwent velopharyngeal closure for velopharyngeal insufficiency following palatoplasty. To reduce the risk of complications attributed to GSD-0, general anesthesia was administered using a total intravenous anesthesia (TIVA) technique with propofol and remifentanil, along with supplemental glucose-containing intravenous fluids. Her blood glucose remained stable, intraoperative body temperature ranged from 36.5 to 37.2°C, and the velopharyngeal closure was completed without any adverse events.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom